Shravya Kichena

Shravya Kichena

Auto-generated profile, based on publicly available information

Shravya Kichena

Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in MedEdPublish
Verified
Journal Article
Open access
LNLokesh Nagineni
Lokesh Nagineni
SKShravya Kichena
Shravya Kichena
EBEmily Bateman Barton
Emily Bateman Barton
KTKei Takigawa
Kei Takigawa
NHNathan Holland
Nathan Holland
JCJessica A Chacon
Jessica A Chacon
Background: Studies show that the introduction of early public health interventions correlates with decreased rates of transmission and reductions in mortality resulting from epidemic or pandemic events. Methods: Medical educators and students from Texas Tech University Health Sciences Center El Paso created the El Paso-Health Education and Awareness Team (EP-HEAT) to educate at-risk populations in the border region. The English and Spanish material created by EP-HEAT included information about disease symptoms, transmission, preventive measures and mental health resources. An online, anonymous survey was distributed to attendees to obtain feedback on the provided coronavirus disease (COVID-19) educational material. Results: The results showed that over 90% of participants agreed that the informational pamphlets increased their awareness and knowledge of COVID-19. Conclusions: In this study, educators and students created COVID-19-related material in virtual workshops and pamphlets, designed to increase knowledge about COVID-19, mitigate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and how to address mental health issues related to the pandemic. A majority of participants agreed or strongly agreed that the COVID-19 material developed by EP-HEAT helped raise awareness, understanding, and the importance of education about SARS-CoV-2/COVID-19.

9 April 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
SKShravya Kichena
Shravya Kichena
ELEmily Limmer
Emily Limmer
DKDario Kivelevitch
Dario Kivelevitch
Cutaneous pseudolymphoma (CPL) is a reactive polyclonal T- or B-cell lymphoproliferative process that histopathologically and/or clinically imitates cutaneous lymphoma. We report the case of a 62-year-old woman with a poorly defined, erythematous plaque with papules on the dorsal nose that had been present for years. This lesion was biopsied as an atypical T-cell infiltrate and was clinically diagnosed as a pseudolymphoma. After unsuccessful treatments with mometasone and tacrolimus, the patient was started on tapinarof cream 1%. After 10 months of treatment, there was clinical improvement of the plaque and papules with only slight residual erythema. Further studies and reports will help elucidate the role of tapinarof as a therapeutic option for pseudolymphoma. Based on its safety profile and promising results in other inflammatory and hyperproliferative disorders, it could be considered in refractory cases.